Baker Brothers files Form 144; TARA brokered sales Feb–Mar 2026 (TARA)

Rhea-AI Filing Summary

Baker Brothers Life Sciences filed a Form 144 reporting proposed sales of Common Stock of TARA. The filing lists three brokered sales: 322,039 shares on 02/24/2026 for $1,944,922; 947,479 shares on 02/25/2026 for $5,501,316; and 424,125 shares on 03/04/2026 for $2,654,641.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Canaccord Genuity LLC 99 High Street, Suite 1200 Boston MA 02110	461723	2701080.00	53587260	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/06/2026	See Remark 2	Broker			461723	03/06/2026	See Remark 2

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Baker Brothers Life Sciences, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/24/2026	322039	1944922.00
Baker Brothers Life Sciences, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/25/2026	947479	5501316.00
Baker Brothers Life Sciences, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	03/04/2026	424125	2654641.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for TARA disclose?

It disclosed proposed brokered sales of TARA common stock by Baker Brothers Life Sciences. The filing lists three sales on 02/24/2026, 02/25/2026, and 03/04/2026 with share counts and dollar amounts shown for each transaction.

How many shares did Baker Brothers sell on February 25, 2026 for TARA?

Baker Brothers sold 947,479 shares on 02/25/2026. The filing pairs that share count with a reported gross amount of $5,501,316, indicated as a brokered transaction in the Form 144 excerpt.

What proceeds are shown for the March 4, 2026 TARA sale?

The March 4, 2026 sale is reported as 424,125 shares for $2,654,641. That figure appears alongside the sale date and share count in the Form 144 excerpt, identified as a brokered Common Stock sale by Baker Brothers Life Sciences.

Who is the reporting seller in this Form 144 for TARA?

The seller reported is Baker Brothers Life Sciences, L.P. The excerpt lists that entity's name and address for each sale entry and identifies the transactions as Common Stock brokered sales on the specified dates.

Does the Form 144 indicate how the sales were executed for TARA shares?

Yes; the excerpt identifies the transactions as brokered sales. Each sale line pairs a date, share count, and gross dollar amount and lists the sales method as broker, consistent with the brokered sale entries in the Form 144 excerpt.